Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Brain Cancer treatment details. Chemotherapy. Radiation. University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States

Survival: 10.5 months
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Temodar
Country: United States
City/State/Province: Houston, Texas
Hospital: University of Texas M.D. Anderson Cancer Center
Journal: Link
Date: 3/2002

Patients: This Phase II study involved 44 patients with recurrent glioblastoma multiforme.

Treatment: The treatment consisted of temozolomide (temodar) and the matrix metalloproteinase inhibitor marimastat (MRM) after radiation therapy.

Toxicity: The most notable toxicity was arthropathy. Joint complaints were reported in 21 patients (47%) and were grade 3 or 4 in 17 patients (38%). Other grade 3-4 toxicities included: vomiting, fatigue/lethargy, thrombocytopenia, seizure, hyperglycemia, and thrombosis.

Results: Median overall survival (measured from the first day of treatment) was 45 weeks (10.5 months).

E-mail to a Friend More Information